Prophylactic intramedullary fixation for bisphosphonate-related subtrochanteric stress fracture.
Bisphosphonates are the most widely used medication to treat osteoporosis. Recent reports have documented an association between chronic bisphosphonate use and femoral insufficiency fractures. This article describes an 84-year-old woman with a diagnosis of osteoporosis treated with bisphosphonate medications for 9 years. She presented with left groin pain, and magnetic resonance imaging revealed a subtrochanteric femoral stress fracture. Operative and nonoperative management was discussed with the patient, and she chose to undergo prophylactic intramedullary nailing of the left femur. Six months postoperatively, she was asymptomatic and ambulating without assistive devices.This article describes successful management of a bisphosphonate-related femoral insufficiency fracture. The presence of groin or thigh pain in a patient taking bisphosphonates should alert the physician to the possibility of insufficiency fracture of the proximal femur, and plain radiographs should be obtained. If these radiographs show lateral cortical thickening, consideration should be given to prophylactic intramedullary femoral nailing. The risks and benefits of prophylactic fixation vs conservative management should be discussed with the patient. A recent series showed a high failure rate with conservative treatment of these fractures. A dialogue with the primary care physician should be initiated to determine the necessity of bisphosphonate therapy, and, if deemed necessary, an alternative class of medications should be considered.
Department of Orthopaedics, Temple University Hospital, Philadelphia, PA 19140, USA. john. fowler@tuhs.temple.edu
John R
JR
Fowler
Katharine
K
Criner
Matthew R
MR
Craig
D000369:Aged, 80 and over; D050071:Bone Density Conservation Agents / Q000009:adverse effects / Q000627:therapeutic use; D004164:Diphosphonates / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D005594:Fracture Fixation, Intramedullary / Q000379:methods*; D015775:Fractures, Stress / Q000139:chemically induced* / Q000175:diagnosis / Q000601:surgery*; D006801:Humans; D010024:Osteoporosis / Q000150:complications / Q000188:drug therapy; D016896:Treatment Outcome
D050071:Bone Density Conservation Agents; D004164:Diphosphonates